Please login to the form below

Not currently logged in
Email:
Password:

CDMO

This page shows the latest CDMO news and features for those working in and with pharma, biotech and healthcare.

Emergent inks $174m deal with AstraZeneca to manufacture COVID-19 vaccine

Emergent inks $174m deal with AstraZeneca to manufacture COVID-19 vaccine

Follows initial deal agreed in June. US-based CDMO Emergent BioSolutions has agreed a deal with AstraZeneca to expand manufacturing of the latter's potential COVID-19 vaccine. ... As COVID-19 vaccine candidates progress through the pipeline, Emergent

Latest news

  • Mallinckrodt reaches tentative $1.6bn opioid settlement Mallinckrodt reaches tentative $1.6bn opioid settlement

    Last September, Mallinckrodt sold off its contract development and manufacturing organisation (CDMO) for $250m to private equity firm H.I.G.

  • Mallinckrodt offloads CDMO for $250m Mallinckrodt offloads CDMO for $250m

    Move follows US opioid settlement. Mallinckrodt has agreed to sell its contract development and manufacturing organisation (CDMO) BioVectra for $250m to private equity firm H.I.G. ... Following the announcement of Mallinckrodt's CDMO sale, shares jumped

  • Amicus forms gene therapy manufacturing partnership with Catalent Amicus forms gene therapy manufacturing partnership with Catalent

    The alliance announced yesterday adds to a similar strategic manufacturing collaboration with Thermo Fisher Scientific, the contract development and manufacturing organisation (CDMO) which also has late-stage clinical and commercial-scale

  • Catalent preps for complex therapy boom with $1.2bn Paragon buy Catalent preps for complex therapy boom with $1.2bn Paragon buy

    The CDMO has a 25-year history in the production of gene therapies, including adeno-associated virus (AAV) vectors, the most commonly used delivery system, as well as plasmids and lentivirus

  • DSM merges pharma unit with Patheon DSM merges pharma unit with Patheon

    CDMO) Patheon to create a $2.6bn outsourcing giant. ... The combined company will address a combined CDMO market for outsourced APIs and finished dosage forms of around $30bn and growing in the mid- to high-single digits, according to DSM.

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Deal Watch December 2016 Deal Watch December 2016

    say. Lonza's $5.5bn acquisition of the CDMO Capsugel caused a fall in their share price of 10% compared to the previous week, although it has now bounced back.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • apceth Biopharma appoints Dusan Kosijer as CFO apceth Biopharma appoints Dusan Kosijer as CFO

    He joins the cell therapy company from Accovion GmbH. Contract development and manufacturing organisation (CDMO) apceth Biopharma has promoted Dusan Kosijer to chief financial officer (CFO), a role that will see ... therapy. “We will continue to be

  • Francois Chouinard moves from Halo Pharma to Ropack Pharma Solutions Francois Chouinard moves from Halo Pharma to Ropack Pharma Solutions

    He will be responsible for the business development of the Long Island, New York drug development facilities at the contract development and manufacturing organisation (CDMO) / contract manufacturing organisation (CMO). ... His many years of success and

  • RRD International hires Ulrich Thienel as CDMO RRD International hires Ulrich Thienel as CDMO

    Company expands leadership team with former Takeda VP. RRD International, a specialised product development company, has appointed Dr Ulrich Thienel as its new chief development and medical officer (CDMO). ... As CDMO, Thienel will provide scientific,

  • Aesica creates commercial MD role Aesica creates commercial MD role

    The contract development and manufacturing (CDMO) firm Aesica said the creation of the role reflects the company's decision to focus on 'core commercial activities'. ... He joins from the CDMO Catalent where he was responsible for the global provision of

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Piramal | Healthcare

    Pharma Solutions is the contract development and manufacturing (CDMO) division of Piramal | Healthcare, a part of the Piramal Enterprise.

  • SCM Pharma

    SCM Pharma is a contract development & manufacturing organisation (CDMO) that develops and makes novel, difficult and dangerous drugs on behalf of our clients.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics